Ligand Pharmaceuticals LGND Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's goodwill?
- Ligand Pharmaceuticals (LGND) reported goodwill of $101.54M in Q1 2026.
- How has Ligand Pharmaceuticals's goodwill changed year-over-year?
- Ligand Pharmaceuticals's goodwill decreased by 0.0% year-over-year, from $101.54M to $101.54M.
- What is the long-term trend for Ligand Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's goodwill has grown at a -11.7% compound annual growth rate (CAGR), from $189.66M to $101.54M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.